3-77040832-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001290065.2(ROBO2):c.-1872A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290065.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROBO2 | NM_001395656.1 | c.47A>G | p.Tyr16Cys | missense_variant | Exon 1 of 28 | ENST00000696593.1 | NP_001382585.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROBO2 | ENST00000696593.1 | c.47A>G | p.Tyr16Cys | missense_variant | Exon 1 of 28 | NM_001395656.1 | ENSP00000512738.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152024Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249560Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135402
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461818Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727204
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74256
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 16 of the ROBO2 protein (p.Tyr16Cys). This variant is present in population databases (rs779002469, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with ROBO2-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ROBO2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at